Roundhill Investments · 2024-05-20 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | +$236,791 | — | — | $54.1M | 每日估算 |
| 2026-07-30 | -$8.5M | — | — | $54.1M | 每日估算 |
| 2026-07-27 | +$7.7M | — | — | $62.2M | 每日估算 |
| 2026-07-26 | -$8.5M | — | — | $54.1M | 每日估算 |
| 2026-03-31 | -$100,917 | $2.9M | $3.0M | $51.4M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
LLY Eli Lilly & Co | EC | 9,003 | $8.3M | 16.10% |
NVO Novo Nordisk A/S | EC | 183,834 | $6.8M | 13.13% |
Mount Vernon Liquid Assets Portfolio, LLC Mount Vernon Liquid Assets Portfolio, LLC | STIV | 6,243,130 | $6.2M | 12.14% |
PFE Pfizer Inc | EC |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| SEC 月度 |
| 2026-02-28 | $0 | $0 | $0 | — | SEC 月度 |
| 2026-01-31 | +$13.2M | $13.2M | $0 | — | SEC 月度 |
| 138,419 |
| $3.9M |
| 7.56% |
VKTX Viking Therapeutics Inc | EC | 83,569 | $2.7M | 5.29% |
1801 Innovent Biologics Inc | EC | 242,500 | $2.6M | 5.11% |
1672 Ascletis Pharma Inc | EC | 1,133,000 | $2.4M | 4.67% |
AMGN Amgen Inc | EC | 5,762 | $2.0M | 3.94% |
ROP Roche Holding AG | EC | 5,146 | $2.0M | 3.92% |
AZN AstraZeneca PLC | EC | 9,819 | $1.9M | 3.76% |
128940 Hanmi Pharm Co Ltd | EC | 5,593 | $1.9M | 3.66% |
ZEAL Zealand Pharma A/S | EC | 40,685 | $1.9M | 3.60% |
4519 Chugai Pharmaceutical Co Ltd | EC | 32,800 | $1.8M | 3.45% |
REGN Regeneron Pharmaceuticals Inc | EC | 2,218 | $1.7M | 3.33% |
2196 Shanghai Fosun Pharmaceutical Group Co Ltd | EC | 662,500 | $1.7M | 3.26% |
1093 CSPC Pharmaceutical Group Ltd | EC | 1,298,000 | $1.5M | 2.93% |
GUBRA Gubra A/S | EC | 22,723 | $1.2M | 2.42% |
GPCR Structure Therapeutics Inc | EC | 25,378 | $1.2M | 2.38% |
3933 United Laboratories International Holdings Ltd/The | EC | 954,000 | $1.2M | 2.27% |
MBX MBX Biosciences Inc | EC | 34,264 | $1.0M | 1.99% |
GILD Gilead Sciences Inc | EC | 7,043 | $981,583 | 1.91% |
RYTM Rhythm Pharmaceuticals Inc | EC | 8,463 | $736,027 | 1.43% |
4507 Shionogi & Co Ltd | EC | 32,700 | $713,032 | 1.39% |
BHVN Biohaven Ltd | EC | 53,094 | $449,175 | 0.87% |
FGXXX First American Government Obligations Fund | STIV | 388,153 | $388,153 | 0.75% |
WVE WaVe Life Sciences Ltd | EC | 32,778 | $237,641 | 0.46% |
CRBP Corbus Pharmaceuticals Holdings Inc | EC | 22,131 | $207,810 | 0.40% |